chrisvoncsefalvay/vaers-outcomes huggingface dataset:
After getting vaccine in the last week of May I developed rash all over my body.; Dermatologist diagnosed it as Lichen planus with blisters; Dermatologist diagnosed it as Lichen planus with blisters; This is a spontaneous report from a contactable consumer (Patient). A 33-year-old-female non pregnant patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown), via an unspecified route of administration, administered in left arm on 09MAY2021 at 14:00 (at the age of 33 years old) as a single dose for COVID-19 immunisation. Patient's medical history none reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. No concomitant medications were reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 24May2021 at 13:00 the patient experienced rash all over body after getting vaccine in the last week of May and dermatologist diagnosed it as Lichen planus with blisters. The patient received treatment for the events. The patient visited physician office due to events. The outcome of the events was not recovered.  The lot number for the vaccine (BNT162B2) was not provided and will be requested during follow up.
The last time l got the flu shot l got horribly sick; Initial information received on 24-Jan-2023 regarding an unsolicited valid Social Media non-serious case received from a consumer/non-healthcare professional.  This case involves an unknown age and unknown gender patient who got the flu shot and got horribly sick last time while receiving vaccine influenza vaccine.  It is unknown if the patient had any medical history, concomitant disease or risk factor.   The patient's past medical treatment(s), concomitant medication(s) and family history were not provided.   On an unknown date, the patient had received a dose of suspect influenza vaccine produced by unknown manufacturer lot number not reported via unknown route in unknown administration site (dose, frequency, route, formulation, strength, lot/batch number and expiration date: not provided) as Prophylactic vaccination.  On an unknown date the patient had developed a non-serious the last time l got the flu shot l got horribly sick (illness) (unknown latency) following the administration of influenza vaccine.  It is unknown if there were lab data/results available.   Action taken- Not applicable.  It was not reported if the patient received a corrective treatment for the event (Illness).  At time of reporting, the outcome was Unknown.
Vomiting.  24hrs Diarrhea    30 hrs Headache Muscle Ache Chills Hives  (severe) Nausea  Stomach pain Anaphylaxis
mom called @ 315PM to advise nurse that pt had been crying constantly since 115PM; mom unable to console pt; nurse heard shrill crying in background during phone call; crying seems to be from leg pain according to mom; t97.9 R;
Pt complained of diarrhea, achey joints, flu like symptoms and headache beginning approximately one hour post injection. During the day, the pt reported that the headache improved but she felt tired and sleepy. on 1/20/00 reported diarrhea improving, headache better and complained of intercostal soreness.
This spontaneous report has been received from a pharmacist referring to a patient of unknown age and gender. The patient had been vaccinated with ZOSTAVAX (lot# and expiration date were not reported) on 24-JAN-2014. On 24-JAN-2014, the patient had been vaccinated with a dose of ZOSTAVAX (strength, dose, route, lot# and expiration date were not reported). On 31-MAY-2016 the patient received a second dose of ZOSTAVAX lot # L034727 (reported as 1034727), expiration date 09-DEC-2016 (extra dose administered). No adverse events reported. Additional information has been requested.
5 days of sneezing, running nose, watering eyes and itching of nose and eyes-antihistamine, ZYRTEC.
Fever, chills, body aches, very tired. Reduced appetite. These symptoms started 9 hr after the shot and lasted for about 96 hours. Pt's face was olive green.
grandma called today stating pt had sterile abscess in lt thigh from inj given on 16NOV95;dx 29NOV95 by MD @ ER;warm soaks qid & liquid Motrin for discomfort;11DEC95 pt no further problems;
Patient developed redness and swelling of right arm from shoulder to wrist 24 hours after receiving vaccines. The patient also developed several hives. The redness and swelling improved with antihistamines.
SIGNS AND SYMPTOMS INCLUDE 3 INCH RASH ON ABDOMEN AT THE UMBILICUs 6 days post immunization.
Sweats, chills, body aches (severe) lasted about 12 hours. Treated with Advil.
Case number PHEH2016US017542 is an initial spontaneous report received from a health care professional on 06 Jul 2016. This report refers to an unknown demographics patient. Past medical history and concomitant medications were not reported. The patient received seasonal influenza vaccine, (manufacturer: unknown, batch number: not reporter) and tetanus vaccine (manufacturer: unknown, batch number: not reported) on an unspecified date. On an unknown date, after received the tetanus and seasonal influenza vaccine (manufacturer: unknown, batch number: not reporter) on an unspecified date. On an unknown date, after receiving the tetanus and seasonal influenza vaccine patient's arm were swelled, blew up. The outcome, seriousness and causality of event were not reported.
52 yo female s/p full COVID Pfizer vaccination: dose 1 on 3/19, dose 2 on 4/9. Pt reports new onset cough, muscle/body aches, new loss of taste/smell, and congestion/runny nose on 8/3. Denies known exposure to COVID-19. PCR test results positive on 8/3. Patient receives  casirivimab/imdevimab infusion on 8/5.
Fully vaccinated, boosted on 1/17/22.  Symptomatic COVID breakthrough infection with inpatient hospital stay.
Nausea, weakness, body aches (especially left hip) for 2/3 days
Patient who is an adult was given 0.25mL of the Moderna Bivalent COVID booster vaccine.  No adverse events were noted at the time of the administration.
Information has been received from a registered nurse concerning a 14 year old white female with attention deficit/hyperactivity disorder and mental illness who on 03-JAN-2007, at 1230, was vaccinated intramuscularly into left deltoid with the first 0.5 ml dose of GARDASIL vaccine (yeast). (Lot number 654741/1208F). On 26-JAN-2007, the patient was vaccinated intramuscularly into left deltoid with the second dose of GARDASIL vaccine (yeast), (Lot number 654741/1208F). There was no illness at the time of vaccination. Concomitant therapy given on 03-JAN-2007 intramuscularly into right deltoid included the first dose of MENACTRA vaccine (dip toxoid) (Lot number U1808AA). Concomitant therapy also included CONCERTA. The patient's mother reported that on 26-JAN-2007 night, the patient "tripped out". The patient threw things, her eyes rolled into back of head and passes out for 3 minutes. The patient had never had anything like that before. The mother reported that the patient was "like a zombie this weekend". The patient was pale on 29-JAN-2007 and continued with anger outbursts over the weekend. There was no fever and no further episodes. The patient was not evaluated by anyone over the weekend. The mother called to seek medical attention on 29-JAN-2007. The doctor advised her to continue to monitor and to call if increased with concerns. No further call came back regarding symptoms. 3 to 4 days post the onset of the events (approximately 30-JAN-2007) the patient recovered. No further information is available.
pt recvd vax & devel elevated liver function tests & was hospitalized w/chest pain; addtl detals will be  requested;
Serum sickness reaction - started with rash 9 days after receiving MMR, DTAP and IPV.  This evolved into full blown serum sickness with fever, vomiting, arthralgias and angioedema.  She improved significantly after systemic steroids and made a full and complete recovery. 01/19/07-records received and reviewed for DOS 07/29-08/01/06. DC DX: Serum sickness Several metabolic derangements including hyponatremia, hypocalcemia, hypoproteinemia Anemia, borderline microcytic Developed rash along with vomiting and fever. Ondate of vaccine had onset of dry cough. On 7/21/06 developed rash treated with Amoxicillin, rash worsened, feet became bluish hot to touch and swollen, treated with Benadryl changed to Ceftin. Developed nausea vomiting fever.  RX with Solu-Medrol and antibiotics discontinued
ACHES AND PAINS ESPECIALLY IN THE LEGS Extreme Fatigue Lost taste and ability to smell anything Very hoarse cough low grade fever nausea headaches sinus drainage sore throat
No additional AE; TE on VARIVAX; This spontaneous report was received from a registered nurse and refers to a patient of unknown age and gender. Information regarding the patient's pertinent medical history, historical drugs, concurrent conditions, concomitant therapies, and previous drug reactions or allergies was not reported.  On 24-FEB-2023, the patient  was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, 0.5 milliliter, lot #U019908, expiration date: 24-JUN-2023, administered for prophylaxis (strength, and route of administration were not provided).  The vaccine was stored in a temperature of 7.2F/(6°F up to 14°F) for 1 hour 22 minutes. There was a previous temperature excursion of 10.9F/(6°F up to 14°F) for 1 hour 18 minutes 36 seconds. No additional adverse event/No PQC.
On 03/04/16, 83 yo F presented to clinic for a Nurse Only visit for pneumococcal vaccination. Pt was administered 0.5 mL Pneumococcal Conjugate 13-Valent (Prevnar 13) IM in left deltoid (NDC: 0005-1971-01; Mfg: Wyeth-Ayerst; Lot #M51192). On 03/07, pt called and reported that her left arm was swollen and painful to the touch. Pt returned to clinic and MD evaluation found LUE redness, tenderness and warmth around vaccine injection in left deltoid. Pt prescribed cephalexin 250 mg PO 3 times daily x 7 days, diclofenac 50 mg PO daily after lunch and was instructed to apply warm compresses to the affected area. On 03/11, pt again returned to clinic for evaluation. Although LUE swelling continued, pt's pain had improved. Labs were collected and found to be negative for infection, rhabdo and inflammation. Pt was told to continue antibiotic as prescribed. No new treatment interventions ordered.
Pt received 2nd dose of Pfizer Covid-19 Vaccine; Pt was advised to stay for 15 after dose due to not having any previous hx of anaphylaxis. about 10 min after vaccine administration pt c/o itchiness in throat and tingling sensation on lips. Rapid Response was called. VSS BP: 127/68 HR 96 SPO2 98%. Rn administered Benadryl per Dr order. Pt was given precautions per RN and left clinic with steady gait, a&o and with no other s/s.
allergic rxn-red, raised, hot;5cm in diameter, fever, gen malaise;advised APAP ES DPH for comfort;
Fever blisters in oral cavity at the tongue and gums. Temperature up to 101.4 degrees. Lesions were in the mouth for several days. Painful.
A mother of a female pt reported that her daughter developed a nonspecific allergy while on therapy with hepatitis B vax.
A report has been received from a Health Professional concerning an infant, subject of unknown gender, who had been receiving Nasal FLUMIST QUADRIVALENT, 0.2 Millilitres, Once/Single administration. FLUMIST QUADRIVALENT started on 12-Jan-2016. The FLUMIST vaccine that was given on 12-Jan-2016 to the patient had expired on 07-Jan-2016. The vaccine was not expired when it was received at the HCP office. The outcome of the event of received a dose of expired FLUMIST-medication error is unknown. The report was considered to be non-serious by the company physician.
Tested negative for antibodies after receiving both doses of vaccine; This spontaneous case was reported by a physician and describes the occurrence of SARS-COV-2 ANTIBODY TEST NEGATIVE (Tested negative for antibodies after receiving both doses of vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Kidney transplant.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SARS-COV-2 ANTIBODY TEST NEGATIVE (Tested negative for antibodies after receiving both doses of vaccine). At the time of the report, SARS-COV-2 ANTIBODY TEST NEGATIVE (Tested negative for antibodies after receiving both doses of vaccine) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The patient received both doses of Moderna Covid-19 vaccine.  The patient was tested for antibodies and the result came out negative.  It was reported that  the test would be repeated. Action taken with M-RNA-1273 (Moderna Covid-19 Vaccine) in response to the event was not applicable.
A few weeks after my second shot (at the beginning of April, having had the 2nd shot on 3/13/20), I lost all sense of taste and smell.  About 2.5 months later, both returned.  I'm fine now.
Strange Reactions: -tingly face, fingers, and limbs -desensitized fingertips -cramp in left palm -numbness on left elbow -hot flashes throughout whole body -dark red and hot limbs with bulging veins that are painful -triggered acid reflux -out of breath. Even something as simple as rolling over in bed made me feel weak, lightheaded, and gasping for air -increased heart rate -skin sensitivity. I was walking outside in the rain and the rain felt like acid on my skin. -tingly feeling running up my back and into the back of my head -extreme brain fog -sweating randomly -extremely itchy skin but I did not have hives. Some of my fingers got slightly puffy and the feeling of this paired with the itchiness reminded me of my penicillin reactions. -tremors and muscle spasms -Random feelings of ?electric shock? in my limbs and fingers. That?s really the best way to describe that.  Tingliness, tremors, muscle spasms and hot flashes are still occurring
Patient complained of chest pain 20 min after receiving the vaccine.  Patient placed on the stretcher and called 911.  Vitals good but he was brought to the hospital for further workup.
Extreme pain to the point I need to take pain medicine, super tired to the point I can barley function, fever of 102.7, shaking shivering, skin buttoning, just genuinely unwell.
Pfizer-BioNTech COVID-19 Vaccine EUA  reported headache that she did not have prior to injection
Tested COVID19 positive; Lack of efficacy; Fatigue; Fever; Chills; Cough; Runny nose; Dizziness; A spontaneous report was received from a consumer concerning a 70-year-old,female patient, who received the first dose of the Moderna's COVID-19 vaccine (mRNA-1273) and experienced fever/ pyrexia, chills, cough, runny nose/ rhinorrhoea, dizziness, fatigue, Covid positive/ SARS-CoV-2 test positive, and lack of efficacy/therapeutic product ineffective.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 05 Mar 2021, prior to the onset of the events, the patient received the first of two planned doses of mRNA-1273 (Batch Number: 027A21A) intramuscularly for prophylaxis of COVID-19 infection.   On 05 Mar 2021, the same day as receiving the vaccine, the patient experienced fever, chills, cough, runny nose, dizziness, fatigue and lack of efficacy.    On 11 Mar 2021, the patient tested positive for COVID-19.  Treatment information included corsin(?), acetaminophen, Vitamin C and zinc.  Action taken with mRNA-1273 in response to the events was unknown; however, the patient was advised to not take the second dose.  The event, lack of efficacy, was considered resolved on 11-Mar-2021. The outcome of the events, fever, chills, cough, runny nose, dizziness, fatigue, and Covid positive, was unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Hospitalization for COVID, CHF 1/10/22-1/18/22. Treated with baricitinib, dexamethasone, zinc 50 mg daily, vitamin D3 50 mcg daily and vitamin C 1,000 mg daily
Patient was given Pfizer as dose 2 in COVID series, instead of Moderna (dose 1).
Small Rash on inside of both arms and chest(slight) 6/5/21 3:00 approximately. Rash increased on chest, neck, upper back. 6/6/21  approximately 7:45 pm after shower.  More blotch than rash on 6/7/21. slight itch irritation upon touch.  Mild headache, within 24 hrs of injection. Lasted 24 hrs.  Arm sore 6/4/21 evening which increased through Sunday night. Soreness Monday 6/7/21 but eased up.
SWELLING, REDNESS AND PAINFUL AT LEFT ARM. AFTER THE PATIENT TOOK BENADRYL AND IBUPROFEN, SHE FELT NO PAIN ANY MORE BUT THE REDNESS AND SWELLING STILL THERE.
a bad night after dose 2; chills after dose 2; fatigue after dose 2; headache after dose 2; muscle pain after dose 2; joint pain after dose 2; fever after dose 2; nausea after dose 2; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (a bad night after dose 2), CHILLS (chills after dose 2), FATIGUE (fatigue after dose 2), HEADACHE (headache after dose 2) and MYALGIA (muscle pain after dose 2) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007M20A and 007M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Pain. Concomitant products included MELOXICAM for Pain.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In 2021, the patient experienced VACCINATION COMPLICATION (a bad night after dose 2), CHILLS (chills after dose 2), FATIGUE (fatigue after dose 2), HEADACHE (headache after dose 2), MYALGIA (muscle pain after dose 2), ARTHRALGIA (joint pain after dose 2), PYREXIA (fever after dose 2) and NAUSEA (nausea after dose 2). At the time of the report, VACCINATION COMPLICATION (a bad night after dose 2), CHILLS (chills after dose 2), FATIGUE (fatigue after dose 2), HEADACHE (headache after dose 2), MYALGIA (muscle pain after dose 2), ARTHRALGIA (joint pain after dose 2), PYREXIA (fever after dose 2) and NAUSEA (nausea after dose 2) outcome was unknown.            The patient's conmeds included  blood pressure medication and cholesterol medication. No treatment was reported.  The reporter did not consent for follow up and remains anonymous on the report.   This case was linked to MOD-2021-402860, MOD-2021-402843 (Patient Link).   Reporter did not allow further contact
Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Apr-2021 at 11:01 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 03-Apr-2021 at 11:01 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). In 2021, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Age of patient was reported as 60.85 for dose administered on 03-Apr-2021. No concomitant medications were reported.  Batch number 030B21 administered on 03-Apr-2021 underwent temperature excursion with temperature of 34 degrees Fahrenheit at 09:00 AM. This vial was moved to fridge on 30-Mar-2021 and beyond use date for the vial was reported as 29-Apr-2021. Product moved to clinic on 03-Apr-2021.  Vial was in cooler storage and was not in frozen storage during high-pace COVID-19 vaccination at around 2021. Vials were only punctured right before administration. Vaccines were not frozen at time of administration. It was reported that each time a vial was put into a cooler, sometimes there was a period of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34- or 35-degree Fahrenheit. Temperature recordings were taken using a Fisher brand traceable temperature monitor at every hour.  No treatment medications were reported.
This spontaneous report as received from a pharmacist refers to a patient of unknown age. On 30-SEP-2014 the patient was vaccinated with PNEUMOVAX23 injection (dosing regimen unspecified). On 30-SEP-2014, the patient inadvertently administered 2 doses of PNEUMOVAX23. No adverse effect reported. The outcome of inadvertently administered 2 doses of PNEUMOVAX23 and no adverse effect reported is unknown. There was no product quality complaint involved. Additional information has been requested.
1:15 pm c/c stomach pain and H.A. provided with rest. Noted irregular heart rhythm. 1510-left with mother, informed cardiac eval needed.
This spontaneous report as received from a physician refers to a 50 year old male patient, who had multiple vaccines in the past because of being in the miliary. In June 2013 the patient was vaccinated with a dose of ZOSTAVAX (Lot # not reported) (0.65 ml, subcutaneous route). Concomitant therapy was not reported. In 2013, the patient developed bruising and induration on the upper arm of the patient, as well as a diffused papular small rash on arms and legs. The patient sought medical attention, went to health care professional. Laboratory diagnostic studies were not performed.  At the time of the report the patient's outcome was reported as recovered. Additional information has been requested.
soreness of arm after first dose of covid vaccine; This is a spontaneous report from a contactable consumer (patient). This 82 years old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number/Exp. date unknown) on 21Jan2021 via unknown route of administration at single dose on left arm for COVID-19 immunisation. Relevant medical history included back problems which was diagnosed prior to receiving the Covid vaccine and was treated with epidural injection with no side effects. Relevant concomitant medication were not provided. The patient reported that he received first dose of COVID-19 vaccine on 21Jan2021and experienced soreness of arm after first dose of COVID-19  vaccine. The outcome for other events was not recovered. The patient stated that she will receive her second epidural injection on 02Feb2021 but also reported that her second COVID-19 vaccine shot is scheduled for 11Feb2021. The patient inquired if there is any study, or danger in having the epidural shot and Covid shot close together or if she needs to space them apart.   The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.